James Netterville
Faculty Member

  1. Viable biobanking of primary head and neck squamous cell carcinoma. Godoy JM, Sewell A, Johnston B, Brown BT, Lu X, Sinard RJ, Rohde S, Mannion K, Netterville JL, Yarbrough WG (2013) Laryngoscope 123(3): 641-5
    › Primary publication · 23299699 (PubMed)
  2. Tumors of the cervical sympathetic chain--diagnosis and management. Langerman A, Rangarajan SV, Athavale SM, Pham MQ, Sinard RJ, Netterville JL (2013) Head Neck 35(7): 930-3
    › Primary publication · 23002012 (PubMed)
  3. The usefulness of a yearly head and neck surgery trip to rural Kenya. Pearce EC, Mainthia R, Freeman KL, Mueller JL, Rohde SL, Netterville JL (2013) Otolaryngol Head Neck Surg 149(5): 727-32
    › Primary publication · 24046273 (PubMed)
  4. The mortality observed-to-expected ratio in otolaryngology. Bennett ML, Morath JM, Yarbrough D, Sinard R, Netterville J, Eavey RD (2013) Otolaryngol Head Neck Surg 148(1): 59-63
    › Primary publication · 23087367 (PubMed)
  5. Clinical practice guideline: tympanostomy tubes in children--executive summary. Rosenfeld RM, Schwartz SR, Pynnonen MA, Tunkel DE, Hussey HM, Fichera JS, Grimes AM, Hackell JM, Harrison MF, Haskell H, Haynes DS, Kim TW, Lafreniere DC, LeBlanc K, Mackey WL, Netterville JL, Pipan ME, Raol NP, Schellhase KG (2013) Otolaryngol Head Neck Surg 149(1): 8-16
    › Primary publication · 23818537 (PubMed)
  6. Clinical practice guideline: Tympanostomy tubes in children. Rosenfeld RM, Schwartz SR, Pynnonen MA, Tunkel DE, Hussey HM, Fichera JS, Grimes AM, Hackell JM, Harrison MF, Haskell H, Haynes DS, Kim TW, Lafreniere DC, LeBlanc K, Mackey WL, Netterville JL, Pipan ME, Raol NP, Schellhase KG (2013) Otolaryngol Head Neck Surg 149(1 Suppl): S1-35
    › Primary publication · 23818543 (PubMed)
  7. Complications of alloderm and dermamatrix for parotidectomy reconstruction. Athavale SM, Phillips S, Mangus B, Datta J, Sinard RJ, Netterville JL, Burkey BB, Yarbrough WG (2012) Head Neck 34(1): 88-93
    › Primary publication · 21469246 (PubMed)
  8. BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors. Dahlman KB, Xia J, Hutchinson K, Ng C, Hucks D, Jia P, Atefi M, Su Z, Branch S, Lyle PL, Hicks DJ, Bozon V, Glaspy JA, Rosen N, Solit DB, Netterville JL, Vnencak-Jones CL, Sosman JA, Ribas A, Zhao Z, Pao W (2012) Cancer Discov 2(9): 791-7
    › Primary publication · 22798288 (PubMed) · PMC3449158 (PubMed Central)
  9. Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Murphy BA, Dietrich MS, Wells N, Dwyer K, Ridner SH, Silver HJ, Gilbert J, Chung CH, Cmelak A, Burkey B, Yarbrough WG, Sinard R, Netterville J (2010) Head Neck 32(1): 26-37
    › Primary publication · 19626644 (PubMed)
  10. Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, Baumann J, Burkey B, Netterville J, Sinard R, Yarbrough WG, Cmelak AJ, Slebos RJ, Shyr Y, Parker J, Gilbert J, Murphy BA (2010) Ann Oncol 21(4): 864-70
    › Primary publication · 19850643 (PubMed) · PMC2844946 (PubMed Central)